Table 2 Antimicrobial susceptibilities of C. difficile isolates.

From: Whole-genome sequencing reveals nosocomial Clostridioides difficile transmission and a previously unsuspected epidemic scenario

PCR ribotype (n)

Vancomycin

Tigecycline

Metronidazole

Moxifloxacin

% Sa

MICb range

% S

MIC range

% S

MIC range

% S

MIC range

001 (5)

100

0.19–0.5

100

≤0.016–0.023

100

0.064–0.19

20

0.5–>32

014/020 (5)

100

0.25–0.38

100

≤0.016

100

0.032–0.125

100

0.125–0.75

027 (5)

100

0.016–0.5

100

≤0.016–0.023

100

0.125–0.25

0

>32

078 (5)

100

0.25–0.5

100

≤0.016–0.023

100

0.032–0.047

0

>32

106 (5)

100

0.125–0.5

100

≤0.016–0.023

100

0.064–0.125

40

0.5–>32

  1. a% S, proportion of susceptible isolates (%); bMIC, minimum inhibitory concentration (mg/L).